Skip to main content
. 2017 Dec 1;7(12):2465–2477.

Figure 3.

Figure 3

A and B. Kaplan-Meier analysis of overall survival (OS) and cumulative recurrence rates in 393 patients, by SLC29A1 expression. Significantly greater OS and lower cumulative recurrence rates occurred in the SLC29A1 high group, compared with the SLC29A1 low group. C-E. The prognostic significance of SLC29A1 in hepatocellular carcinoma (HCC) patients with normal alpha-fetoprotein (AFP) levels (P=0.041), without microvascular invasion (MVI; P=0.01), and Barcelona Clinic Liver Cancer (BCLC) Staging 0-A (P=0.014). F. Adjuvant transcatheter arterial chemoembolization (TACE) did not reduce the early recurrence rate in SLC29A1 high HCC patients (P=0.006).